User Profile
Select your user profile
Article

Molecular solutions

Transforming testing & treatment together

An investment in a Roche solution is an investment in your future. Our firm commitment to research and development allows us to offer a robust end-to-end portfolio that is uniquely designed to address the real-world needs of laboratories, their customers, and the patients they serve.

advancing-diagnostic-innovation

Advanced diagnostic innovation

As pioneers of polymerase chain reaction (PCR) technology, scientific and clinical excellence is in our DNA.

Roche systems and assays are the preferred choice in clinical trials across the industry and are also trusted with keeping the blood supply safe.

Beyond pathogen detection, our suite of viral load monitoring assays and leadership in HPV Primary Screening empower laboratories to better inform clinical decisions.

Further advances in oncology testing with the cobas® EGFR Mutation Test v2 bring clearer results and confident decisions to those who are most vulnerable.

Advancing assay performance and design

Roche continually monitors the evolving diseases landscape to identify strategies to combat and control their spread. Optimising assay performance and design ensures more confident detection and differentiation, allowing patients to benefit from the most informed decision possible.

Ensuring confidence across platforms

Roche molecular systems are a valuable addition to any laboratory. From our earlier diagnostic offerings through to the universal concept design of cobas® 6800/8800 Systems, results generated on Roche systems are proven to be standardised and comparable across all platforms.1-3*

Roche results are proven standard across systems and assays

Comprehensive solutions to meet your molecular testing needs

IVD

In vitro diagnostic (IVD) assays

Roche assays have played an integral role in defining and shaping treatment guidelines, establishing treatment cut-offs, and as a benchmark for assay performance.

Learn More
LDT

Laboratory developed tests (LDTs)

Flexibly expand, customize, automate, and standardize your laboratory’s LDT  portfolio with our diverse offering of nucleic acid purification and qPCR solutions.

Learn More
cobas® prime Pre-analytical System

Molecular Automation Solutions

Experience a new paradigm in workflow efficiency. Roche offers a range of standalone, physical, and virtual automation solutions that minimise laboratory inefficiency and maximise organisational value.

Learn More
cobas® infinity laboratory solution

Intelligent Workflow Management

Get an integrated view of your laboratory ecosystem. With advanced IT automation, you can confidently meet key performance indicators, raise the bar on laboratory automation, and do more with your time.

Learn More
cobas® infinity laboratory solution

Molecular Point of Care

Explore the impact standardized,  mobilized and connected testing can have on both patient experiences and point-of-care efficiency.

Learn More
cobas eplex® system

Syndromic testing

Discover the sample-to-answer solution that streamlines the diagnostic workflow from order entry to final report.

Learn More
Medical staff cheking a patient

Total commitment deserves the total point-of-care PCR solution

Enable the answers you need to support efficient, exemplary care

References

  1. Adams P, Vancutsem E, Nicolaizeau C, Sevais JY, et al. Multicenter evaluation of the cobas® HIV-1 Quantitative nucleic acid test for use on the cobas® 4800 system for the quantification of HIV-1 plasma viral load. J Clin Virol. 2019 May;114:43-49
  2. Massoumy B, Bremer B, Lehmann P, Marins E G, et al. Commutability and concordance of four hepatitis B virus DNA assays in an international multicenter study. Therap Adv Gastroenterol. 2017 Aug;10(8):609-61
  3. Vermehren J, Stelzl E, Maasoumy B, Michel-Treil V, et al. Multicenter Comparison Study of both Analytical and Clinical Perfromance across Four Roche Hepatitis C Virus RNA Assays Utilizing Different Platforms. Journal of Clinical Microbiology. 2017 Mar;55(4):1131-1139